Cardioncology: From Molecular Mechanisms to Advanced Imaging and New Treatments
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 1241
Special Issue Editors
Interests: heart failure; hypertension; cardiomyopathies; advanced cardiac multimodality imaging; cardioncology
Special Issues, Collections and Topics in MDPI journals
Interests: heart failure; cardiomyopathies; pediatric cardiology; cardioncology
Special Issues, Collections and Topics in MDPI journals
Interests: dyslipidemia; ischemic heart disease; atrial fibrillation; hypertension; acute coronary syndrome; heart failure; cardioncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Advances in cancer therapies have significantly increased patient survival rates, but they carry the risk of cardiotoxicity, which requires effective monitoring and management.
Knowledge of the potential cardiovascular side effects of different classes of cancer therapies can improve understanding of their dose- and time-dependent impacts.
Shared inflammatory processes and immune system alterations characterize both cancer and cardiovascular disease. The immunological consequences of cancer treatments, especially with new biological therapies such as immunotherapy, underscore the need to explore the role of the immune system in determining cardiotoxicity at the molecular level.
Furthermore, despite the existence of several international guidelines and position papers regarding cardiovascular monitoring and management of patients receiving anticancer drugs, their limited empirical basis makes it difficult to determine a practical approach suitable for each clinical scenario.
This Special Issue “Cardioncology: From Molecular Mechanisms to Advanced Imaging and New Treatments” invites you to submit review articles, clinical cases or original papers with the aim to:
- Delve into the molecular mechanisms underlying the interplay between cardiovascular and cancer-related issues;
- Delve into the role of advanced imaging techniques in the diagnosis of early cardiotoxicity and monitoring of possible cardiovascular side effects of various classes of chemotherapeutics and radiotherapy;
- Deepen our understanding of the role of serum cardiac biomarkers in the diagnosis of early cardiotoxicity and monitoring of possible cardiovascular side effects of various classes of chemotherapeutics and radiotherapy;
- Delve into arrhythmic complications: diagnosis, monitoring and treatment;
- Describe the latest advances in treatments of cardiotoxicity.
Dr. Carla Contaldi
Dr. Giuseppe Pacileo
Prof. Dr. Paolo Calabrò
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiotoxicity
- echocardiography
- cardiac magnetic resonance
- cardiac computed tomography
- serum cardiac biomarkers
- cancer therapy
- arrhythmias
- cardiotoxicity treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
